Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, Belgium, Russia, UK, Taiwan, and China sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research. Insilico Medicine pioneered the applications of the generative adversarial networks (GANs) and reinforcement learning for generation of novel molecular structures for the diseases with a known target and with no known targets. In addition to working collaborations with the large pharmaceutical companies, the company is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with LifeExtension.com, the company launched a range of nutraceutical products compounded using the advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI. In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI companies in its potential for social impact. In 2018, the company was named one of the global top 100 AI companies by CB Insights. In 2018 it received the Frost & Sullivan 2018 North American Artificial Intelligence for Aging Research and Drug Development Award accompanied with the industry brief.
B2B
51 to 100
Series D
$401.3M
Scaling Up
2014
Pharmaceuticals and Medical Products
Healthcare
Health Care Facilities & Hospitals
Increasing Probabilities of success
Decreasing Costs of Medicine
AI Scoring & Analysis
Increase Efficiency
Production
Yes
Active
Machine Learning
Natural Language Processing
Software
Machine Learning Engineer
Shanghai , Pudong
Machine Learning Research Scientist
Shanghai , Pudong
PandaOmics Global Product Manager
Business Development Consultant
Remote, Remote
Sales Development Representative
Shanghai , Pudong
AI/ML Professionals
Want to work at Insilico Medicine?
We can introduce you to the right person at Insilico Medicine
20
3
$116.67M
Company was founded 2014 and it took almost 7 years (Jun 2021) to raise first external round
Investors
Interested in researching Insilico Medicine?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Insilico Medicine
Potential Customers
Interested in what they do or partnership?
Learn more about how they work